Joseph Monahan, Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS), sold 5,000 shares at $13.06 ($65K) on 2023-02-15, disclosed to the SEC on 2023-02-17.
Open-market sale of $65k ACRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ACRS | SELL | 2023-06-22 | $123K | — | Filing → |
| ACRS | SELL | 2023-03-03 | $588K | — | Filing → |
| ACRS | SELL | 2022-12-16 | $79K | — | Filing → |